NEW YORK STATE COMMON RETIREMENT FUND - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.5%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$223
-9.0%
17,551
+0.8%
0.00%
Q2 2023$245
-34.5%
17,405
-28.1%
0.00%
-100.0%
Q1 2023$374
-30.0%
24,205
-25.7%
0.00%0.0%
Q4 2022$534
-99.9%
32,595
+0.0%
0.00%0.0%
Q3 2022$603,000
+41.2%
32,588
+0.4%
0.00%0.0%
Q2 2022$427,000
+200.7%
32,474
+111.7%
0.00%
Q1 2022$142,000
-48.7%
15,343
-45.9%
0.00%
Q4 2021$277,000
-71.3%
28,335
-0.3%
0.00%
-100.0%
Q3 2021$965,000
-26.6%
28,413
-20.9%
0.00%0.0%
Q2 2021$1,315,000
-46.3%
35,920
-34.2%
0.00%
-66.7%
Q1 2021$2,449,000
-21.4%
54,6060.0%0.00%0.0%
Q4 2020$3,116,000
+38.4%
54,606
+24.4%
0.00%0.0%
Q3 2020$2,252,000
-18.0%
43,905
-4.5%
0.00%
-25.0%
Q2 2020$2,745,000
+132.0%
45,970
+59.9%
0.00%
+100.0%
Q1 2020$1,183,000
+2.2%
28,742
+54.5%
0.00%
+100.0%
Q4 2019$1,158,000
+94.9%
18,600
+6.3%
0.00%0.0%
Q3 2019$594,000
+74.2%
17,500
+15.9%
0.00%
Q2 2019$341,000
+48.3%
15,100
+52.5%
0.00%
Q1 2019$230,000
+10.6%
9,9000.0%0.00%
Q4 2018$208,000
-45.7%
9,9000.0%0.00%
Q3 2018$383,000
-1.8%
9,9000.0%0.00%
Q2 2018$390,000
+97.0%
9,9000.0%0.00%
Q1 2018$198,000
+21.5%
9,900
+37.5%
0.00%
Q4 2017$163,0007,2000.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$18,687,87215.44%
Redmile Group, LLC 5,582,105$86,243,5223.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,218,638$80,627,9571.80%
BRAIDWELL LP 3,241,351$50,078,8731.65%
Parkman Healthcare Partners LLC 491,772$7,597,8771.65%
Sunesis Advisors, LLC 96,299$1,487,8201.07%
ARMISTICE CAPITAL, LLC 4,100,000$63,345,0000.91%
Deep Track Capital, LP 1,363,201$21,061,4550.86%
AlphaCentric Advisors LLC 72,500$1,120,1250.77%
Ikarian Capital, LLC 174,510$2,696,1790.61%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders